Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25)

被引：0
|
作者：
Roniel Cabrera
Miguel Ararat
Mengde Cao
Yiling Xu
Clive Wasserfall
Mark A. Atkinson
Chen Liu
David R. Nelson
机构：
[1] University of Florida,Section of Hepatobiliary Diseases, Department of Medicine
[2] University of Florida,Department of Pathology, Immunology, and Laboratory Medicine
来源：
Digestive Diseases and Sciences | 2010年 / 55卷
关键词：
Soluble IL-2 receptor alpha chain (sIL-2RA); IL-2 signaling; T cell immunosuppression; Liver cancer; Serum; Soluble factors; Tumor tolerance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：484 / 495
页数：11
相关论文
共 38 条
  • [1] Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25)
    Cabrera, Roniel
    Ararat, Miguel
    Cao, Mengde
    Xu, Yiling
    Wasserfall, Clive
    Atkinson, Mark A.
    Liu, Chen
    Nelson, David R.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) : 484 - 495
  • [2] Influence of Serum and Soluble CD25 (sCD25) on Regulatory and Effector T-cell Function in Hepatocellular Carcinoma
    Cabrera, R.
    Ararat, M.
    Eksioglu, E. A.
    Cao, M.
    Xu, Y.
    Wasserfall, C.
    Atkinson, M. A.
    Liu, C.
    Nelson, D. R.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 72 (04) : 293 - 301
  • [3] Serum levels of soluble CD25 as a marker for hepatocellular carcinoma
    Cabrera, Roniel
    Fitian, Asem I.
    Ararat, Miguel
    Xu, Yiling
    Brusko, Todd
    Wasserfall, Clive
    Atkinson, Mark A.
    Liu, Chen
    Nelson, David R.
    ONCOLOGY LETTERS, 2012, 4 (04) : 840 - 846
  • [4] The soluble form of the IL-2 receptor (sCD25) as a novel biomarker for hepatocellular carcinoma.
    Ararat, M. A.
    Fitian, A. I.
    Brusko, T.
    Xu, Y.
    Wasserfall, C.
    Atkinson, M.
    Liu, C.
    Allegra, C. J.
    Nelson, D.
    Cabrera, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] Soluble CD25 as a predictor of hepatocellular carcinoma compared with alpha-fetoprotein
    Abdelfattah, Shaymaa Nafady
    Haseeb, Alaa Farouk
    Tawfik, Mohammad Mohammad
    Khalil, Doaa Mahmoud
    Attia, Dina
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 5 (02) : 140 - 146
  • [6] SERUM CD25 LEVELS DURING INTERLEUKIN-2 THERAPY - DOSE DEPENDENCE AND CORRELATIONS WITH CLINICAL TOXICITY AND LYMPHOCYTE SURFACE SCD25 EXPRESSION
    BOGNER, MP
    VOSS, SD
    BECHHOFER, R
    HANK, JA
    ROPER, M
    POPLACK, D
    HAMMOND, D
    SONDEL, PM
    JOURNAL OF IMMUNOTHERAPY, 1992, 11 (02): : 111 - 118
  • [7] IDENTIFICATION OF CD4(+)CD25(HIGH) REGULATORY T CELL SUBSETS REFLECTING PROGRESSION OF HEPATOCELLULAR CARCINOMA
    Takata, Yashiko
    Nakamoto, Yasunari
    Nakada, Akiko
    Terashima, Takeshi
    Mizukoshi, Eishiro
    Kaneko, Shuichi
    HEPATOLOGY, 2008, 48 (04) : 1014A - 1014A
  • [8] Adult T-cell leukemia/lymphoma following elevation of serum levels of soluble cytokine receptors, sCD25 and sCD30
    Shigeki Takemoto
    Koji Uzawa
    Kazuki Morita
    Ratiorn Pornkuna
    Yoshio Haga
    Masako Iwanaga
    Yasuko Sagara
    Fumio Kawano
    Toshiki Watanabe
    Retrovirology, 11 (Suppl 1)
  • [9] The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis
    Zhao, Zi-Jing
    Lian, Hong-Yun
    Li, Wei-Jing
    Zhang, Qing
    Ma, Hong-Hao
    Wang, Dong
    Zhao, Yun-Ze
    Zhu, Ting
    Li, Hua-Lin
    Huang, Xiao-Tong
    Wang, Tian-You
    Zhang, Rui
    Cui, Lei
    Li, Zhi-Gang
    JORNAL DE PEDIATRIA, 2025, 101 (02) : 194 - 201
  • [10] Changes of CD4~+ CD25~+ Regulatory T Cells in Peripheral Blood in Patients with Hepatocellular Carcinoma Before and after TACE
    熊斌
    冯敢生
    罗仕华
    梁惠民
    邱凌云
    郑传胜
    柳曦
    周国锋
    Journal of Huazhong University of Science and Technology(Medical Sciences), 2008, (06) : 645 - 648
1234